Clinical Trial

Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

Study acronym: SHORT-OPC
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a randomized clinical trial comparing the outcomes of short-course chemoradiation consisting in stereotactic boost to the gross tumor and de-esclalated chemoradiation to the elective neck in human papilloma associated oropharynx cancer vs. the current standard 7-week course chemoradiation.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2019-11-23; most recent amendment 2025-05-14.
Status change: Not Yet Recruiting → Recruiting 2020-04-13
Trial Details
NCT Number NCT04178174
Lead Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Collaborators: M.D. Anderson Cancer Center, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Jewish General Hospital
Conditions Head and Neck Cancer, Oropharynx Cancer, Human Papilloma Virus
Enrollment 360 participants
Start Date 2020-02-23
Primary Completion 2027-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-18